The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica reduces obesity via skeletal muscle AMPK and PPARα

References

• Ahn IS, Do MS, Choi BH, Kong CS, Kim SO, Han MS, Park KY. (2006). Reduced leptin secretion by fucoidan-added Kochujang and anti-adipogenic effect of fucoidan in mouse 3T3-L1 adipocytes. J Food Sci 11:31–35.
   Google Scholar
• Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, Gonzalez FJ. (1998). Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem, 273, 5678–5684.
   PubMed Web of Science ®Google Scholar
• Boozer CN, Daly PA, Homel P, Solomon JL, Blanchard D, Nasser JA, Strauss R, Meredith T. (2002). Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial. Int J Obes Relat Metab Disord, 26, 593–604.
   PubMed Web of Science ®Google Scholar
• Boozer CN, Nasser JA, Heymsfield SB, Wang V, Chen G, Solomon JL. (2001). An herbal supplement containing Ma Huang-Guarana for weight loss: a randomized, double-blind trial. Int J Obes Relat Metab Disord, 25, 316–324.
   PubMed Web of Science ®Google Scholar
• Carling D. (2004). The AMP-activated protein kinase cascade–a unifying system for energy control. Trends Biochem Sci, 29, 18–24.
   PubMed Web of Science ®Google Scholar
• Colberg SR, Simoneau JA, Thaete FL, Kelley DE. (1995). Skeletal muscle utilization of free fatty acids in women with visceral obesity. J Clin Invest, 95, 1846–1853.
   PubMed Web of Science ®Google Scholar
• Collier CA, Bruce CR, Smith AC, Lopaschuk G, Dyck DJ. (2006). Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. Am J Physiol Endocrinol Metab, 291, E182–E189.
   PubMed Web of Science ®Google Scholar
• Fleming RM. (2008). Safety of ephedra and related anorexic medications. Expert Opin Drug Saf, 7, 749–759.
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhou Y, Xu A, Wu D. (2008). Effects of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cells. Biol Pharm Bull, 31, 1716–1722.
   PubMed Web of Science ®Google Scholar
• Haller CA, Benowitz NL. (2000). Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids. N Engl J Med, 343, 1833–1838.
   PubMed Web of Science ®Google Scholar
• Hardie DG. (2008). AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond), 32 Suppl 4, S7–12.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Carling D, Carlson M. (1998). The AMP-activated/SNF1 protein kinase subfamily: metabolic sensors of the eukaryotic cell? Annu Rev Biochem, 67, 821–855.
   PubMed Web of Science ®Google Scholar
• Hardie DG, Hawley SA, Scott JW. (2006). AMP-activated protein kinase–development of the energy sensor concept. J Physiol (Lond), 574, 7–15.
   Google Scholar
• Huang L, Wen K, Gao X, Liu Y. (2010). Hypolipidemic effect of fucoidan from Laminaria japonica in hyperlipidemic rats. Pharm Biol, 48, 422–426.
   PubMed Web of Science ®Google Scholar
• Jeong S, Han M, Lee H, Kim M, Kim J, Nicol CJ, Kim BH, Choi JH, Nam KH, Oh GT, Yoon M. (2004). Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice. Metab Clin Exp, 53, 1284–1289.
   PubMed Web of Science ®Google Scholar
• Kemp BE, Mitchelhill KI, Stapleton D, Michell BJ, Chen ZP, Witters LA. (1999). Dealing with energy demand: the AMP-activated protein kinase. Trends Biochem Sci, 24, 22–25.
   PubMed Web of Science ®Google Scholar
• Kroetz DL, Yook P, Costet P, Bianchi P, Pineau T. (1998). Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J Biol Chem, 273, 31581–31589.
   PubMed Web of Science ®Google Scholar
• Lee WJ, Kim M, Park HS, Kim HS, Jeon MJ, Oh KS, Koh EH, Won JC, Kim MS, Oh GT, Yoon M, Lee KU, Park JY. (2006). AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochem Biophys Res Commun, 340, 291–295.
   PubMed Web of Science ®Google Scholar
• Lee Y, Yu X, Gonzales F, Mangelsdorf DJ, Wang MY, Richardson C, Witters LA, Unger RH. (2002). PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissue. Proc Natl Acad Sci USA, 99, 11848–11853.
   PubMed Web of Science ®Google Scholar
• Liu JF, Ma Y, Wang Y, Du ZY, Shen JK, Peng HL. (2011). Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress. Phytother Res, 25, 588–596.
   PubMed Web of Science ®Google Scholar
• Long YC, Zierath JR. (2006). AMP-activated protein kinase signaling in metabolic regulation. J Clin Invest, 116, 1776–1783.
   PubMed Web of Science ®Google Scholar
• López-Soriano J, Chiellini C, Maffei M, Grimaldi PA, Argilés JM. (2006). Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity. Endocr Rev, 27, 318–329.
   PubMed Web of Science ®Google Scholar
• Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH. (1997). Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes, 46, 983–988.
   PubMed Web of Science ®Google Scholar
• Simoneau JA, Veerkamp JH, Turcotte LP, Kelley DE. (1999). Markers of capacity to utilize fatty acids in human skeletal muscle: relation to insulin resistance and obesity and effects of weight loss. FASEB J, 13, 2051–2060.
   PubMed Web of Science ®Google Scholar
• Suzuki A, Okamoto S, Lee S, Saito K, Shiuchi T, Minokoshi Y. (2007). Leptin stimulates fatty acid oxidation and peroxisome proliferator-activated receptor alpha gene expression in mouse C2C12 myoblasts by changing the subcellular localization of the alpha2 form of AMP-activated protein kinase. Mol Cell Biol, 27, 4317–4327.
   PubMed Web of Science ®Google Scholar
• Xue B, Kahn BB. (2006). AMPK integrates nutrient and hormonal signals to regulate food intake and energy balance through effects in the hypothalamus and peripheral tissues. J Physiol (Lond), 574, 73–83.
   Google Scholar
• Xue J, Ding W, Liu Y. (2010). Anti-diabetic effects of emodin involved in the activation of PPARgamma on high-fat diet-fed and low dose of streptozotocin-induced diabetic mice. Fitoterapia, 81, 173–177.
   PubMed Web of Science ®Google Scholar
• Yan ZH, Karam WG, Staudinger JL, Medvedev A, Ghanayem BI, Jetten AM. (1998). Regulation of peroxisome proliferator-activated receptor alpha-induced transactivation by the nuclear orphan receptor TAK1/TR4. J Biol Chem, 273, 10948–10957.
   PubMed Web of Science ®Google Scholar
• Yoon M. (2009). The role of PPARalpha in lipid metabolism and obesity: focusing on the effects of estrogen on PPARalpha actions. Pharmacol Res, 60, 151–159.
   PubMed Web of Science ®Google Scholar
• Yoon M. (2010). PPARa in obesity: sex difference and estrogen involvement. PPAR Res, 2010, 584296.
   PubMedGoogle Scholar
• Yoon KH, Lee HY, Jung YS, Seo BI, Park KY, Yoon M, Shin SS. (2010). Modulation of obesity by Gyeongshingangjeehwan 18 in ob/ob mice. Kor J Herbology 25:1–9.
   Google Scholar
• You JS, Sung MJ, Chang KJ. (2009). Evaluation of 8-week body weight control program including sea tangle (Laminaria japonica) supplementation in Korean female college students. Nutr Res Pract, 3, 307–314.
   PubMed Web of Science ®Google Scholar
• Zarain-Herzberg A, Rupp H. (2002). Therapeutic potential of CPT I inhibitors: cardiac gene transcription as a target. Expert Opin Investig Drugs, 11, 345–356.
   PubMedGoogle Scholar
• Zheng CD, Duan YQ, Gao JM, Ruan ZG. (2010). Screening for anti-lipase properties of 37 traditional Chinese medicinal herbs. J Chin Med Assoc, 73, 319–324.
   PubMed Web of Science ®Google Scholar
• Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest, 108, 1167–1174.
   PubMed Web of Science ®Google Scholar